Intelligent Bio Solutions Inc. (INBS) vs Lexaria Bioscience Corp. (LEXX)
A side-by-side comparison of Intelligent Bio Solutions Inc. and Lexaria Bioscience Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INBS
Intelligent Bio Solutions Inc.
$1.60HealthcareDelayed quote: Oct 6, 2026, 12:29 PM EDT
LEXX
Lexaria Bioscience Corp.
$2.89HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Total return — INBS vs LEXX
growth of $100 · dividends reinvested · last 6yINBS -100.0% (-78.9%/yr)LEXX -95.9% (-41.2%/yr)LEXX compounded faster over this window
Log scale — wide-divergence pair
INBS LEXX
INBS vs LEXX: by the numbers
- •INBS is the larger company ($5M vs $5M market cap).
- •Both run net losses; INBS's is the smaller (-294.91% vs -3985.58% net margin).
- •INBS grew revenue faster over the past five years (19.95% vs 12.92% CAGR).
Metrics side by side
Valuation
| Metric | INBS | LEXX |
|---|---|---|
| P/S ratio | 1.26 | 24.57 |
| P/B ratio | 0.96 | 1.01 |
Profitability
| Metric | INBS | LEXX |
|---|---|---|
| Gross margin | 48.63% | 100.00% |
| Operating margin | -305.03% | -1683.01% |
| Net margin | -294.91% | -3985.58% |
| ROE | -225.57% | -163.18% |
| ROIC | -179.58% | -175.26% |
Growth (annualized)
| Metric | INBS | LEXX |
|---|---|---|
| Revenue CAGR (5Y) | 19.95% | 12.92% |
| Total return CAGR (5Y) | -80.26% | -50.86% |
Frequently asked
- Which has grown faster, INBS or LEXX?
- Over the past five years, INBS grew revenue faster — INBS at a 19.95% CAGR versus LEXX at 12.92%.
- How have INBS and LEXX total returns compared?
- Over the past 5 years, INBS delivered -80.26% and LEXX delivered -50.86% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Intelligent Bio Solutions ROELexaria Bioscience ROEIntelligent Bio Solutions operating marginLexaria Bioscience operating marginIntelligent Bio Solutions revenue growthLexaria Bioscience revenue growthIntelligent Bio Solutions free cash flowLexaria Bioscience free cash flow
Intelligent Bio Solutions & Lexaria Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.